However, there is inconsistent evidence for a deleterious effect of AR signaling in ER− breast cancers at a population level, with epidemiologic studies finding harmful [33–35], beneficial [36, 37], and null [5, 14, 38, 39] associations. This evidence concerns the gene AR and breast carcinoma.